Serotonin and emotional processing: Does it help explain antidepressant drug action?

Neuropharmacology

Volumn 55, Issue 6, 2008, Pages 1023-1028

  Harmer, Catherine J ^a  

^a WARNEFORD HOSPITAL   (United Kingdom)

Author keywords

Antidepressants; Emotional processing; Functional neuroimaging; Serotonin

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TRYPTOPHAN;

ANXIETY; ARTICLE; COGNITION; DEPRESSION; DRUG EFFECT; EMOTION; HUMAN; LEARNING; MOOD; NEUROIMAGING; NONHUMAN; PRIORITY JOURNAL; SYMPTOM;

ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; EMOTIONS; HUMANS; SEROTONIN; SEROTONIN UPTAKE INHIBITORS;

EID: 53449096295     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2008.06.036     Document Type: Article

References (67)

1. Anderson I.M., Del-Ben C.M., McKie S., Richardson P., Williams S.R., Elliott R., et al. Citalopram modulation of neuronal responses to aversive face emotions: a functional MRI study. Neuroreport 18 (2007) 1351-1355
2. Beck, A.T., Rush, A.J., Shaw, B.F., Emery, G., 1979. Cognitive Therapy of Depression. New York.
3. Bhagwagar Z., Hafizi S., and Cowen P.J. Acute citalopram administration produces correlated increases in plasma and salivary cortisol. Psychopharmacology (Berl.) 163 (2002) 118-120
4. Booij L., Van der Does A.J., Haffmans P.M., Riedel W.J., Fekkes D., and Blom M.J. The effects of high-dose and low-dose tryptophan depletion on mood and cognitive functions of remitted depressed patients. J. Psychopharmacol. 19 (2005) 267-275
5. Booij L., Van der Does A.J., and Riedel W.J. Monoamine depletion in psychiatric and healthy populations: review. Mol. Psychiatry 8 (2003) 951-973
6. Bouhuys A.L., Geerts E., and Gordijn M.C. Depressed patients' perceptions of facial emotions in depressed and remitted states are associated with relapse: a longitudinal study. J. Nerv. Ment. Dis. 187 (1999) 595-602
7. Bosker F.J., Cremers T.I., Jongsma M.E., Westerink B.H., Wikstrom H.V., and den Boer J.A. Acute and chronic effects of citalopram on postsynaptic 5-hydroxytryptamine (1A) receptor-mediated feedback: a microdialysis study in the amygdala. J. Neurochem. 76 6 (2001) 1645-1655
8. Bradley B.P., Mogg K., and Lee S.C. Attentional biases for negative information in induced and naturally occurring dysphoria. Behav. Res. Ther. 35 (1997) 911-927
9. Bradley B.P., Mogg K., and Williams R. Implicit and explicit memory for emotion-congruent information in clinical depression and anxiety. Behav. Res. Ther. 33 (1995) 755-770
10. Browning M., Reid C., Cowen P.J., Goodwin G.M., and Harmer C. A single dose of citalopram increases fear recognition in healthy subjects. J. Psychopharmacol. 21 (2007) 684-690
11. Burghardt N.S., Sullivan G.M., McEwen B.S., Gorman J.M., and LeDoux J.E. The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine. Biol. Psychiatry 55 (2004) 1171-1178
12. Chen C.H., Suckling J., Ooi C., Fu C.H., Williams S.C., Walsh N.D., et al. Functional coupling of the amygdala in depressed patients treated with antidepressant medication. Neuropsychopharmacology (2007) 10.1038/sj.npp.1301593
13. Cools R., Calder A.J., Lawrence A.D., Clark L., Bullmore E., and Robbins T.W. Individual differences in threat sensitivity predict serotonergic modulation of amygdala response to fearful faces. Psychopharmacology (Berl.) 180 (2005) 670-679
14. Cools R., Robinson O.J., and Sahakian B. Acute tryptophan depletion in healthy volunteers enhances punishment prediction but does not affect reward prediction. Neuropsychopharmacology (2007) 10.1038/sj.npp.1301598
15. Critchley H.D., Lewis P.A., Orth M., Josephs O., Deichmann R., Trimble M.R., and Dolan R.J. Vagus nerve stimulation for treatment-resistant depression: behavioral and neural effects on encoding negative material. Psychosom. Med. 69 1 (2007) 17-22
16. Davidson R.J., Irwin W., Anderle M.J., and Kalin N.H. The neural substrates of affective processing in depressed patients treated with venlafaxine. Am. J. Psychiatry 160 (2003) 64-75
17. Deakin J.F. The role of serotonin in panic, anxiety and depression. Int. Clin. Psychopharmacol. 13 Suppl. 4 (1998) S1-S5
18. Del-Ben C.M., Deakin J.F., Mckie S., Delvai N.A., Williams S.R., Elliott R., et al. The effect of citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: an FMRI study. Neuropsychopharmacology 30 (2005) 1724-1734
19. Elliott R., Rubinsztein J.S., Sahakian B.J., and Dolan R.J. The neural basis of mood-congruent processing biases in depression. Arch. Gen. Psychiatry 59 (2002) 597-604
20. Evers E.A., van derVeen F.M., Jolles J., Deutz N.E., and Schmitt J.A. Acute tryptophan depletion improves performance and modulates the BOLD response during a Stroop task in healthy females. Neuroimage 32 (2006) 248-255
21. Fu C.H., Williams S.C., Brammer M.J., Suckling J., Kim J., Cleare A.J., et al. Neural responses to happy facial expressions in major depression following antidepressant treatment. Am. J. Psychiatry 164 (2007) 599-607
22. Fu C.H., Williams S.C., Cleare A.J., Brammer M.J., Walsh N.D., Kim J., et al. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch. Gen. Psychiatry 61 (2004) 877-889
23. Grillon C., Levenson J., and Pine D.S. A single dose of the selective serotonin reuptake inhibitor citalopram exacerbates anxiety in humans: a fear-potentiated startle study. Neuropsychopharmacology 32 (2007) 225-231
24. Gur R.C., Erwin R.J., Gur R.E., Zwil A.S., Heimberg C., and Kraemer H.C. Facial emotion discrimination: II. Behavioral findings in depression. Psychiatry Res. 42 (1992) 241-251
25. Hafizi S., Chandra P., and Cowen P.J. Trials and tribulations: neurokinin-1 receptor antagonists as novel antidepressants. Br. J. Psychiatry 191 (2007) 282-284
26. Harmer C.J., Bhagwagar Z., Perrett D.I., Vollm B.A., Cowen P.J., and Goodwin G.M. Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacology 28 (2003) 148-152
27. Harmer C.J., Hill S.A., Taylor M.J., Cowen P.J., and Goodwin G.M. Towards a neuropsychological theory of antidepressant drug action: potentiation of norepinephrine activity increases positive emotional bias. Am. J. Psychiatry 160 (2003) 990-992
28. Harmer C.J., Rogers R.D., Tunbridge E., Cowen P.J., and Goodwin G.M. Tryptophan depletion decreases the recognition of fear in female volunteers. Psychopharmacology (Berl.) 167 (2003) 411-417
29. Harmer C.J., Mackay C.E., Reid C.B., Cowen P.J., and Goodwin G.M. Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biol. Psychiatry 59 (2006) 816-820
30. Harmer C.J., Shelley N.C., Cowen P.J., and Goodwin G.M. Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. Am. J. Psychiatry 161 (2004) 1256-1263
31. Hayward G., Goodwin G.M., Cowen P.J., and Harmer C.J. Low-dose tryptophan depletion in recovered depressed patients induces changes in cognitive processing without depressive symptoms. Biol. Psychiatry 57 (2005) 517-524
32. Ickes B.R., Pham T.M., Sanders L.A., Albeck D.S., Mohammed A.H., and Granholm A.C. Long-term environmental enrichment leads to regional increases in neurotrophin levels in rat brain. Exp. Neurol. 164 (2000) 45-52
33. Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am. J. Psychiatry 160 (2003) 13-23
34. Kennedy S.H., Konarski J.Z., Segal Z.V., Lau M.A., Bieling P.J., McIntyre R.S., et al. Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. Am. J. Psychiatry 164 (2007) 778-788
35. Kent J.M., Coplan J.D., and Gorman J.M. Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety. Biol. Psychiatry 44 (1998) 812-824
36. Klaassen T., Riedel W.J., Deutz N.E., and van Praag H.M. Mood congruent memory bias induced by tryptophan depletion. Psychol. Med. 32 (2002) 167-172
37. Knutson B., Wolkowitz O.M., Cole S.W., Chan T., Moore E.A., Johnson R.C., et al. Selective alteration of personality and social behavior by serotonergic intervention. Am. J. Psychiatry 155 (1998) 373-379
38. MacLeod C., Rutherford E., Campbell L., Ebsworthy G., and Holker L. Selective attention and emotional vulnerability: assessing the causal basis of their association through the experimental manipulation of attentional bias. J. Abnorm. Psychol. 111 (2002) 107-123
39. Manji H.K., Drevets W.C., and Charney D.S. The cellular neurobiology of depression. Nat. Med. 7 (2001) 541-547
40. Manji H.K., Quiroz J.A., Sporn J., Payne J.L., Denicoff K., Gray A., et al. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biol. Psychiatry 53 (2003) 707-742
41. Marsh A.A., Finger E.C., Buzas B., Soliman N., Richell R.A., Vythilingham M., et al. Impaired recognition of fear facial expressions in 5-HTTLPR S-polymorphism carriers following tryptophan depletion. Psychopharmacology (Berl.) 189 (2006) 387-394
42. Merens W., Booij L., Haffmans P.M., and Van der Does A.J. The effects of experimentally lowered serotonin function on emotional information processing and memory in remitted depressed patients. J. Psychopharmacol. (2008) 0: 0269881107081531v1
43. Mogg K., and Bradley B.P. Selective orienting of attention to masked threat faces in social anxiety. Behav. Res. Ther. 40 (2002) 1403-1414
44. Mogg K., Bradley B.P., Millar N., and White J. A follow-up study of cognitive bias in generalized anxiety disorder. Behav. Res. Ther. 33 (1995) 927-935
45. Murphy F.C., Sahakian B.J., Rubinsztein J.S., Michael A., Rogers R.D., Robbins T.W., et al. Emotional bias and inhibitory control processes in mania and depression. Psychol. Med. 29 (1999) 1307-1321
46. Murphy F.C., Smith K.A., Cowen P.J., Robbins T.W., and Sahakian B.J. The effects of tryptophan depletion on cognitive and affective processing in healthy volunteers. Psychopharmacology (Berl.) 163 (2002) 42-53
47. Nadeem H.S., Attenburrow M.J., and Cowen P.J. Comparison of the effects of citalopram and escitalopram on 5-Ht-mediated neuroendocrine responses. Neuropsychopharmacology 29 (2004) 1699-1703
48. Neumeister A., Hu X.Z., Luckenbaugh D.A., Schwarz M., Nugent A.C., Bonne O., et al. Differential effects of 5-HTTLPR genotypes on the behavioral and neural responses to tryptophan depletion in patients with major depression and controls. Arch. Gen. Psychiatry 63 (2006) 978-986
49. Norbury R., Mackay C.E., Cowen P.J., Goodwin G.M., and Harmer C.J. Short-term antidepressant treatment and facial processing. Functional magnetic resonance imaging study. Br. J. Psychiatry 190 (2007) 531-532
50. Nutt D.J. The neuropharmacology of serotonin and noradrenaline in depression. Int. Clin. Psychopharmacol. 17 Suppl. 1 (2002) S1-S12
51. Raleigh M.J., McGuire M.T., Brammer G.L., Pollack D.B., and Yuwiler A. Serotonergic mechanisms promote dominance acquisition in adult male vervet monkeys. Brain Res. 559 2 (1991) 181-190
52. Rasmussen-Torvik L.J., and McAlpine D.D. Genetic screening for SSRI drug response among those with major depression: great promise and unseen perils. Depress. Anxiety 24 (2007) 350-357
53. Reilly J.G., McTavish S.F., and Young A.H. Rapid depletion of plasma tryptophan: a review of studies and experimental methodology. J. Psychopharmacol. 11 4 (1997) 381-392
54. Rogers R.D., Tunbridge E.M., Bhagwagar Z., Drevets W.C., Sahakian B.J., and Carter C.S. Tryptophan depletion alters the decision-making of healthy volunteers through altered processing of reward cues. Neuropsychopharmacology 28 (2003) 153-162
55. Roiser J.P., Blackwell A.D., Cools R., Clark L., Rubinsztein D.C., Robbins T.W., et al. Serotonin transporter polymorphism mediates vulnerability to loss of incentive motivation following acute tryptophan depletion. Neuropsychopharmacology 31 (2006) 2264-2272
56. Roiser J.P., Levy J., Fromm S.J., Wang H., Hasler G., Sahakian B.J., et al. The effect of acute tryptophan depletion on the neural correlates of emotional processing in healthy volunteers. Neuropsychopharmacology 10 (2007) 449-461
57. Roiser J.P., Muller U., Clark L., and Sahakian B.J. The effects of acute tryptophan depletion and serotonin transporter polymorphism on emotional processing in memory and attention. Int. J. Neuropsychopharmacol. 10 (2007) 449-461
58. Ruhe H.G., Mason N.S., and Schene A.H. Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Mol. Psychiatry 12 4 (2007) 331-359
59. In: Salkovskis P.M. (Ed). Frontiers of Cognitive Therapy: the State of the Art and Beyond (1997), Guildford Press
60. Schaefer H.S., Putnam K.M., Benca R.M., and Davidson R.J. Event-related functional magnetic resonance imaging measures of neural activity to positive social stimuli in pre- and post-treatment depression. Biol. Psychiatry 60 (2006) 974-986
61. Sharpley A.L., Williamson D.J., Attenburrow M.E., Pearson G., Sargent P., and Cowen P.J. The effects of paroxetine and nefazodone on sleep: a placebo controlled trial. Psychopharmacology (Berl.) 126 (1996) 50-54
62. Sheline Y.I., Barch D.M., Donnelly J.M., Ollinger J.M., Snyder A.Z., and Mintun M.A. Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol. Psychiatry 50 (2001) 651-658
63. Surguladze S.A., Young A.W., Senior C., Brebion G., Travis M.J., and Phillips M.L. Recognition accuracy and response bias to happy and sad facial expressions in patients with major depression. Neuropsychology 18 (2004) 212-218
64. Teasdale J.D., and Russell M.L. Differential effects of induced mood on the recall of positive, negative and neutral words. Br. J. Clin. Psychol. 22 Pt 3 (1983) 163-167
65. Tse W.S., and Bond A.J. Serotonergic intervention affects both social dominance and affiliative behaviour. Psychopharmacology (Berl.) 161 (2002) 324-330
66. van der Veen F.M., Evers E.A., Deutz N.E., and Schmitt J.A. Effects of acute tryptophan depletion on mood and facial emotion perception related brain activation and performance in healthy women with and without a family history of depression. Neuropsychopharmacology 32 (2007) 216-224
67. Wood R.M., Rilling J.K., Sanfey A.G., Bhagwagar Z., and Rogers R.D. Effects of tryptophan depletion on the performance of an iterated Prisoner's Dilemma game in healthy adults. Neuropsychopharmacology 31 (2006) 1075-1084